Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RFA and Chemotherapy for Unresectable Colorectal Cancer Liver Metastases
NCT03127072Phase 4Unknown
- Sponsor
- Fudan University
- Start
- Apr 2017
- Primary completion
- Dec 2019
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Colorectal cancer with liver metastases (CRLM) (2 arms), sponsored by Fudan University. Primary endpoint: Overall Survival at 3 years. Status: unknown.
02
Conditions
Colorectal cancer with liver metastases (CRLM)
Beyond the preview
Go deeper on NCT03127072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03127072.